These final results, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two assistance the concept of concentrating on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues f